Value of two indicators in predicting lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma

LIU Yan; WU Xiaoli; LI Keji; LAI Ping; KOU Sen; QIU Guoyuan

doi:10.7619/jcmp.20211873

Journal of Clinical Medicine in Practice > 2021 > 25(17): 105-108, 113. > DOI: 10.7619/jcmp.20211873

LIU Yan, WU Xiaoli, LI Keji, LAI Ping, KOU Sen, QIU Guoyuan. Value of two indicators in predicting lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma[J]. Journal of Clinical Medicine in Practice, 2021, 25(17): 105-108, 113. DOI: 10.7619/jcmp.20211873

Citation:

PDF (861 KB)

Value of two indicators in predicting lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma

Department of Clinical Laboratory,Panzhihua Central Hospital of Sichuan Province, 617000
Department of Clinical Laboratory,Panzhihua, Sichuan, 617000

More Information

Received Date: May 06, 2021
Available Online: July 22, 2021
Published Date: September 14, 2021

Graphical Abstract

Abstract

Abstract

Objective To explore the relationships between the expressions of thyroglobulin (Tg) measurement in fine-needle aspirates(FNA-Tg), thyroglobulin antibody measurement in fine-needle aspirates (FNA-TgAb) and lymph node metastasis in cervical area of papillary thyroid carcinoma under ultrasound guidance.
Methods Retrospective analysis was performed to collect the clinical data of 114 patients with papillary thyroid cancer accompanying with lymph node metastasis, among whom forty-one patients with lymph node metastasis confirmed by ultrasonography and surgical pathology were included in the metastatic group, and the remaining 73 patients were included in the non-metastatic group. Meanwhile, clinical data of 37 patients with papillary thyroid carcinoma without lymph node metastasis by ultrasonography and surgical pathology were collected and included in the negative control group. All patients included in the study were examined by ultrasound and ultrasound-guided detection of FNA-Tg and FNA-TgAb were performed. The expressions of FNA-Tg and FNA-TgAb under ultrasound guidance were compared, and receiver operator characteristic (ROC) curve was plotted. The value of ultrasound-guided detection of FNA-Tg or FNA-TgAb alone and their combined detection in predicting cervical lymph node metastasis in patients with papillary thyroid carcinoma were compared.
Results The levels of FNA-Tg and FNA-TgAb in the metastatic group were higher than those in the non-metastatic group and the negative control group, and their levels in the non-metastatic group were higher than those in the negative control group (P <0.05). FNA-Tg or FNA-TgAb detection alone and FNA-TG combined with FNA-TgAb detection in patients with papillary thyroid cancer were taken as test variables, while conditions of lymph node metastasis in the cervical region of patients with papillary thyroid cancer were taken as the status variables (1=lymph node metastasis, 0=non-metastasis), the ROC curve of the subjects was drawn. ROC curve results showed that values of the area under the curve(AUC) were both higher than 0.80 by FNA-Tg or FNA-TgAb detection alone and FNA-TG combined with FNA-TgAb detection in predicting cervical lymph node metastasis in patients with papillary thyroidcancer, and the predictive values were both satisfactory. The Cut-off values of FNA-Tg or FNA-TgAb detection alone were 115.959 ng/mL and 9.715 IU/mL, respectively based on the ROC curve.
Conclusion Ultrasound-guided FNA-Tg and FNA-TgAb expressions are closely related with lymph node metastasis in the cervical area in patients with papillary thyroid cancer, and the preoperative detection of FNA-Tg and FNA-TgAb levels under ultrasound guidance in patients with papillary thyroid cancer is considered to be a guidance for determining whether lymph node dissection is needed or not during radical thyroid cancer surgery.
- papillary thyroid cancer,
- ultrasound examination,
- thyroglobulin,
- thyroglobulin antibody,
- lymph node metastasis

FullText(HTML)

References (15)

References

[1]	XU J, LI Z, SU Q, et al. TRIM29 promotes progression of thyroid carcinoma via activating P13K/AKT signaling pathway[J]. Oncol Rep, 2017, 37(3): 1555-1564. doi: 10.3892/or.2017.5364
[2]	NAMBU J, KOBAYASHI T, HASHIMOTO M, et al. H-prune affects anaplastic thyroid cancer invasion and metastasis[J]. Oncol Rep, 2016, 35(6): 3445-3452. doi: 10.3892/or.2016.4759
[3]	KAYALAR A E, EYUPOGLU E E, AKYILDIZ S, et al. Thyroid Carcinoma Presenting as a Dural and Calvarial Metastasis Mimicking a Lipoma With Difficult Diagnosis of the Primary Lesion[J]. J Craniofac Surg, 2018, 29(7): e684-e686. doi: 10.1097/SCS.0000000000004910
[4]	ITO Y, MIYAUCHI A, MASUOKA H, et al. Excellent prognosis of central lymph node recurrence-free survival for cN0M0 papillary thyroid carcinoma patients who underwent routine prophylactic central node dissection[J]. World J Surg, 2018, 42(8): 2462-2468. doi: 10.1007/s00268-018-4497-x
[5]	ALVEAR RODRIGUEZ C A, TOVAR CUEVAS J R. Regression models with asymmetric data for estimating thyroglobulin levels one year after the ablation of thyroid cancer[J]. Stat Methods Med Res, 2019, 28(8): 2258-2275. doi: 10.1177/0962280218764006
[6]	ZHANG X, HOWELL J M, HUANG Y J. Cervical lymph node fine-needle aspiration and needle-wash thyroglobulin reflex test for papillary thyroid carcinoma[J]. Endocr Pathol, 2018, 29(4): 346-350. doi: 10.1007/s12022-018-9547-2
[7]	石文媛, 胡敏霞, 朱强, 等. 甲状腺乳头状癌伴颈部淋巴结转移的超声征象分析[J]. 中华医学杂志, 2016, 96(27): 2165-2168. doi: 10.3760/cma.j.issn.0376-2491.2016.27.011
[8]	刘娜香, 唐丽娜, 沈友洪, 等. 超声引导下细针抽吸活检联合洗脱液测定甲状腺球蛋白诊断甲状腺乳头状癌侧颈区淋巴结转移[J]. 中国介入影像与治疗学, 2019, 16(9): 527-530. https://www.cnki.com.cn/Article/CJFDTOTAL-JRYX201909004.htm
[9]	胡厚洋梁军, 林岩松. 影响分化型甲状腺癌131Ⅰ治疗获得最佳疗效反应的因素分析及治疗后的动态评估[J]. 中国肿瘤临床, 2018, 15(1): 18-21. doi: 10.3969/j.issn.1000-8179.2018.01.715
[10]	LI Y R, CHEN S T, HSEUH C, et al. Risk factors of distant metastasis in the follicular variant of papillary thyroid carcinoma[J]. J Formos Med Assoc, 2016, 115(8): 665-671. doi: 10.1016/j.jfma.2015.07.002
[11]	AL-HILLI Z, STRAJINA V, MCKENZIE T J, et al. Thyroglobulin measurement in fine-needle aspiration improves the diagnosis of cervical lymph node metastases in papillary thyroid carcinoma[J]. Ann Surg Oncol, 2017, 24(3): 739-744. doi: 10.1245/s10434-016-5625-1
[12]	JEON M J, KIM W G, JANG E K, et al. Thyroglobulin level in fine-needle aspirates for preoperative diagnosis of cervical lymph node metastasis in patients with papillary thyroid carcinoma: two different cutoff values according to serum thyroglobulin level[J]. Thyroid, 2015, 25(4): 410-416. doi: 10.1089/thy.2014.0544
[13]	KE Z, LIU Y, ZHANG Y, et al. Diagnostic value and lymph node metastasis prediction of a custom?made panel (thyroline) in thyroid cancer[J]. Oncol Rep, 2018, 40(2): 659-668. http://www.onacademic.com/detail/journal_1000040552801610_b5d8.html
[14]	高海锋, 赵秋剑, 高自颖, 等. 超声引导下淋巴结细针抽吸活组织细胞学检查联合抽吸洗脱液中甲状腺球蛋白检测对甲状腺乳头状癌颈部淋巴结转移的诊断价值[J]. 肿瘤研究与临床, 2019, 31(10): 675-678. doi: 10.3760/cma.j.issn.1006-9801.2019.10.007
[15]	陈荣荣, 王兴田, 陈大伟, 等. 比较细针穿刺细胞学检查、测定穿刺洗脱液甲状腺球蛋白及BRAF基因诊断甲状腺乳头状癌颈部淋巴结转移的效能[J]. 中国医学影像技术, 2019, 35(12): 1828-1832. https://www.cnki.com.cn/Article/CJFDTOTAL-ZYXX201912023.htm

[1]	ZHANG Jingfei, BAI Wenpei, REN Zhenghong, SHI Zhengyuan, WANG Xiaoxue, WANG Zijun. Vitamin D levels in postmenopausal female medical staff and its influencing factors[J]. Journal of Clinical Medicine in Practice, 2023, 27(18): 118-122. DOI: 10.7619/jcmp.20232308
[2]	MA Li, QI Xiaoli, SHI Xiaoyan. Effects of different surgery methods on anti-mullerian hormone level and perioperative indicators in ovarian chocolate cyst patients[J]. Journal of Clinical Medicine in Practice, 2022, 26(14): 79-83. DOI: 10.7619/jcmp.20221252
[3]	SONG Junya, WU Guirong, JIANG Yihua. Kuntai Capsule versus femoston in the treatment of patients with climacteric syndrome[J]. Journal of Clinical Medicine in Practice, 2020, 24(15): 102-104. DOI: 10.7619/jcmp.202015029
[4]	LU Junjun. Effect of hysteroscopic endometrial electrotomy in treatment of patients with refractory dysfunctional uterine bleeding[J]. Journal of Clinical Medicine in Practice, 2020, 24(5): 117-120. DOI: 10.7619/jcmp.202005032
[5]	LUO Na. Effect of Liqi Huatan Xiaozheng Decoction combined with anti-progestin drugs on prognosis of uterine fibroids patients[J]. Journal of Clinical Medicine in Practice, 2019, 23(16): 89-92. DOI: 10.7619/jcmp.201916024
[6]	LI Dan, LI Juan, YUE Mingming, CHEN Fang, HUANG Dandan. Effect of wenjing decoction on serum follicle stimulating hormone, luteinizing hormone, estradiol, progesterone and testosterone of patients with menopathy of excess-cold syndrome[J]. Journal of Clinical Medicine in Practice, 2017, (19): 84-86,90. DOI: 10.7619/jcmp.201719024
[8]	YU Lan, REN Yu. Correlation between obesity and sex hormone level in male patients with type 2 diabetes mellitus[J]. Journal of Clinical Medicine in Practice, 2015, (1): 42-44. DOI: 10.7619/jcmp.201501013
[9]	TONG De-en, ZHAO Fang, LI Dan-dan, QU Di. Effect of estradiol on the negative feedback inhibition of gonadal axis of obesity boys in puberty[J]. Journal of Clinical Medicine in Practice, 2012, (5): 44-46. DOI: 10.3969/j.issn.1672-2353.2012.05.014

Cited By

Cited by

Periodical cited type(7)

1.	冯晓霞，陈玉仙，张晓萍. 妊娠期肝内胆汁淤积症合并乙型肝炎病毒感染与患者妊娠结局相关性研究. 陕西医学杂志. 2025(02): 227-230 .
2.	刘佳，于雅彬，王兰，李英，于欣，蔡永艳，马娜，阎志新. 重症腺病毒肺炎患儿凝血功能和免疫功能特征及其临床意义. 实用临床医药杂志. 2025(05): 122-126 . 本站查看
3.	王晶晶，李萍，高尚啸，周玥. 阶梯护理决策辅助干预在妊娠期肝内胆汁淤积症患者中的应用. 国际护理学杂志. 2024(09): 1625-1629 .
4.	宋对对，牛丽娜，张小娟，马萍，卫晓娟. 妊娠期肝内胆汁淤积症患者不良妊娠结局影响因素. 中国计划生育学杂志. 2024(07): 1586-1590 .
5.	潘伟杰，程福安，李婉莹，林炳柱. NLR和凝血四项与妊娠期肝内胆汁淤积症病情程度的相关性及检测价值. 实用检验医师杂志. 2024(03): 222-224 .
6.	陈慧. 妊娠期肝内胆汁淤积症孕妇血清总胆酸水平和胎儿心脏功能的相关性. 临床研究. 2023(09): 44-46 .
7.	罗钊琰，唐征宇. 茵陈蒿汤加味辅助治疗湿热郁结型妊娠肝内胆汁淤积症的临床效果. 中国社区医师. 2023(36): 64-66 .

Other cited types(1)

Get Citation

PDF

XML

Article views (389) PDF downloads (5) Cited by(8)

Turn off MathJax

Article Contents

Abstract

References

Value of two indicators in predicting lateral cervical lymph node metastasis in patients with papillary thyroid carcinoma